News May 24, 2024 Geistlich receives EU certification for collagen portfolio Geistlich Pharma has received MDR certification for its collagen product range and thus meets the new EU requirements. The products will be used ...
News May 10, 2024 BioVersys extends Series C financing round to 44.9 million Swiss francs BioVersys is bolstering its partnership with GSK in order to accelerate the development of alpibectir for the treatment of tuberculosis. GSK is s...
Aktuell May 24, 2024 Geistlich erhält EU-Zertifizierung für Kollagen-Portfolio Geistlich Pharma hat die MDR-Zertifizierung für seine Kollagen-Produktpalette erhalten und erfüllt damit die neuen EU-Vorschriften. Die Produkte ...
Actualités Dec 19, 2023 Les Grands Titres de Suisse occidentale (Octobre-Décembre 2023) De l’obtention des meilleurs classements en matière d’innovation mondiale à la réalisation d’avancées significatives dans les domaines de la sant...
News Apr 17, 2024 Addex Therapeutics launches spin-off Neurosterix in Geneva with USD 63 million investment Geneva's Addex Therapeutics has teamed up with Perceptive Advisors to launch spin-off Neurosterix, a new player in neurology-focused drug develop...
Aktuell May 10, 2024 BioVersys erweitert Serie-C-Runde auf 44,9 Millionen Franken BioVersys verstärkt die Zusammenarbeit mit GSK, um die Entwicklung von Alpibectir zur Behandlung von Tuberkulose zu beschleunigen. GSK beteiligt ...
News Oct 04, 2023 Atinary Technologies raises USD 5 million to accelerate material and molecular innovation Vaud-based machine learning specialist Atinary Technologies has raised USD 5 million, propelling the start-up towards a new era of material and m...
News Mar 26, 2024 Zurich researchers make cancer therapy effective again Researchers from the University of Zurich and University Hospital Zurich have discovered how mutated blood cancer cells can be made to respond to...
News Oct 23, 2023 Valsynthèse, 40 years of innovation in the canton of Valais From dynamite to pharmaceuticals, Valsynthèse, the 'fine chemistry' business unit of the Société Suisse des Explosifs, celebrates four decades of...
News Mar 13, 2024 PSI developing new cancer therapy Researchers from the Paul Scherrer Institute (PSI) have developed a radiopharmaceutical to combat metastatic neuroendocrine tumors. After having ...
Actualités Oct 23, 2023 Valsynthèse, 40 ans d’innovation en Valais De la dynamite aux produits pharmaceutiques, Valsynthèse, l’unité « chimie fine » de la Société Suisse des Explosifs, fête quatre décennies de so...
News Dec 19, 2023 Top Stories from Western Switzerland (October-December 2023) From achieving top rankings in global innovation to making significant advancements in healthcare and technology, discover Western Switzerland's ...
News Dec 11, 2023 Artbio and Scailyte making headlines in Basel The biotech company Scailyte has raised 8 million US dollars as part of a Series A financing round. For its part, Artbio has raised as much as 90...
Actualités Oct 04, 2023 Atinary Technologies lève USD 5 millions pour accélérer l’innovation matérielle et moléculaire Le spécialiste vaudois de l’apprentissage automatique, Atinary Technologies, a levé USD 5 millions, propulsant la start-up vers une nouvelle ère ...
News Aug 14, 2023 Bern’s thriving ecosystem for life sciences innovation In the heart of Western Switzerland, the canton of Bern has emerged as a location of choice for companies in the life sciences sector.
Aktuell Nov 10, 2023 Forschende heilen Wunden mit Laktobazillen Forschende aus der Schweiz und den USA haben gemeinsam einen Verband entwickelt, der mithilfe von Probiotika Krankheitskeime in chronischen Wunde...
News Jun 28, 2023 DePoly raises CHF 12.3 million to scale its innovative plastic recycling technology Valais-based start-up DePoly, renowned for its revolutionary technology in PET plastic recycling, has recently closed an oversubscribed seed fina...
News Nov 03, 2023 EPFL and Novochizol to collaborate on designing more efficient immunotherapies A groundbreaking collaboration between EPFL's Laboratory of Biomaterials for Immunoengineering and Novochizol aims to revolutionize cancer treatm...